Reperfusion damage or no-reflow damage in primary coronary interventions in acute myocardial infarction?

European Heart Journal

Volumn 23, Issue 14, 2002, Pages 1076-1078

  Widimsky P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CORONARY REPERFUSION; EDITORIAL; EMBOLISM; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; REPERFUSION INJURY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0036629707     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3146     Document Type: Editorial

References (17)

1. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
2. Grines CL, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-9.
3. Weaver WD, Simes RJ, Betriu A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 1997; 278: 2093-8.
4. Zahn R, Schiele R, Schneider S et al. Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of >12-24 h: Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol 2001; 13: 367-72.
5. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of myocardial infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
6. Zahn R, Schiele R, Schneider S et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000; 36: 2064-71.
7. GUSTO IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) angioplasty substudy investigators. N Engl J Med 1997; 336: 1621-8.
8. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823-31.
9. Henriques JPS, Zijlstra F, Ottervanger JP et al. Incidence and clinical significance of distal embolisation during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-7.
10. Forman MB, Perry JM, Wilson BH et al. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991; 18: 911-8.
11. Di Pasquale P, Paterna S, Cannizzaro S, Bucca V. Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects. Int J Cardiol 1994; 43: 43-50.
12. Gibson CM. A union in reperfusion: The concept of facilitated percutaneous coronary intervention. J Am Coll Cardiol 2000; 36: 1497-9.
13. Herrmann HC, Moliterno DJ, Ohman EM et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 2000; 36: 1489-96.
14. Montalescot G, Barragan P, Wittenberg O et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
15. Le May MR, Labinaz M, Davies RF et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001; 37: 985-91.
16. Antoniucci D, Valenti R, Moschi G et al. Primary stenting in nonselected patients with acute myocardial infarction: The Multilink Duet in Acute Myocardial Infarction (MIAMI) trial. Catheter Cardiovasc Interv 2000; 51: 273-9.
17. Belli G, Pezzano A, De Biase AM et al. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Catheter Cardiovasc lnterv 2000; 50: 362-70.